Catch up on news from Murrieta Genomics by checking out our April 2020 newsletter here.
Blog
Like everyone, we are doing what we can to keep ourselves and those we love safe during this trying time.
Today we launched our newsletter, a monthly update to keep everyone in the loop. You can view it here.
John Powers, President of Murrieta Genomics and CEO of SimplSeq, our wholly owned subsidiary, was interviewed recently on Beyone with
Press Releases
This is going to be fun!
We anticipate a high level of demand for our products, as they will allow labs to save money, time and
Murrieta Genomics was recently named as a “company to watch” by The Healthcare Insights, a medical publication that discusses developments
Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc., has filed a new patent application for simplified sample